A

Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti‐C5 therapy

HemaSphere, vol. 10, pp. e70384

Abstract

Abstract Patients with paroxysmal nocturnal hemoglobinuria (PNH) on anti‐C5 often experience extravascular hemolysis with anemia. Iptacopan, the first oral proximal complement inhibitor targeting factor B, has shown efficacy and safety in PNH patients. APPULSE‐PNH (NCT05630001), a phase 3b, single‑arm, open‐label trial, enrolled adult patients with PNH and hemoglobin ≥10 g/dL on stable anti‐C5 for ≥6 months. Patients switched to iptacopan monotherapy (200 mg twice daily; 24 weeks). Primary endpoint: mean hemoglobin change from baseline across four visits (Days 126–168). At baseline, 57.7% of patients had elevated absolute reticulocyte counts (ARCs; above ULN = 123 × 10 9 /L) and 50% had C3 deposition on red blood cells (RBCs) >10%, indicative of extravascular hemolysis. There was a statistically significant increase in hemoglobin during the trial; adjusted mean change from baseline (95% CI) was +2.0 g/dL (1.7–2.3) overall, and in patients with baseline hemoglobin <12 g/dL and ≥12 g/dL, +2.4 (2.0–2.7) and +1.4 (1.0–1.8), respectively. Patients maintained transfusion independence, 92.7% with hemoglobin ≥12 g/dL. Adjusted mean change from baseline (95% CI) in lactate dehydrogenase and ARC were −1.3% (−6.6 to 4.3) and −89.2 × 10 9 /L (−95.5 to −82.9), respectively. Mean (SD) proportion of C3d+ PNH RBCs, assessed by flow cytometry, decreased from 11.0% (8.6) to 0.2% (0.7) at Day 168. No patients had breakthrough hemolysis or major adverse vascular events. FACIT‐Fatigue and treatment satisfaction scores improved by Days 84 and 168. Safety showed consistency with previous iptacopan PNH trials. Iptacopan improved hematologic outcomes in PNH patients with hemoglobin ≥10 g/dL on anti‐C5, maintaining control of intravascular hemolysis and resolving extravascular hemolysis.

Authors 32

  1. King's College Hospital · National Institute for Health and Care Research · European Society for Blood and Marrow Transplantation · European Society for Blood and Marrow Transplantation

    Affiliation as printed

    King's College Hospital NHS London UK

    National Institute for Health and Care Research and Wellcome King's Research Facility London UK

    The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (UK, Italy and the Netherlands) Barcelona Spain

  2. European Society for Blood and Marrow Transplantation · European Society for Blood and Marrow Transplantation

    Affiliation as printed

    French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Paris France

    The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (UK, Italy and the Netherlands) Barcelona Spain

  3. Hospital Clínic de Barcelona

    Affiliation as printed

    Hospital Clínic of Barcelona Barcelona Spain

  4. University of Southern California · USC Norris Comprehensive Cancer Center

    Affiliation as printed

    USC Norris Cancer Center, Keck‐USC School of Medicine Los Angeles California USA

  5. Harvard University · Massachusetts General Hospital

    Affiliation as printed

    Harvard Medical School Boston Massachusetts USA

    Massachusetts General Hospital Boston Massachusetts USA

  6. Prisma Health

    Affiliation as printed

    Prisma Health Cancer Institute Greenville South Carolina USA

  7. New York University · NYU Langone Health

    Affiliation as printed

    NYU Grossman School of Medicine New York New York USA

    NYU Langone Medical Center New York New York USA

  8. Cleveland Clinic

    Affiliation as printed

    Cleveland Clinic Cleveland Ohio USA

  9. Samsung Medical Center · Sungkyunkwan University

    Affiliation as printed

    Samsung Medical Centre, Sungkyunkwan University School of Medicine Seoul Republic of Korea

  10. St James's University Hospital

    Affiliation as printed

    St James's University Hospital Leeds UK

  11. Affiliation as printed

    UOC Oncoematologia, AULSS7 Pedemontana Bassano del Grappa Vicenza Italy

  12. Université Côte d'Azur · Centre Hospitalier Universitaire de Nice

    Affiliation as printed

    Nice University Hospital, Cote d'Azur University Nice France

  13. City Of Hope National Medical Center · City of Hope

    Affiliation as printed

    City of Hope Medical Center Duarte California USA

  14. Affiliation as printed

    Department of Hematology, Cellular Therapy and Medical Oncology Dresden University Medical School Dresden Germany

  15. Azienda Ospedaliero-Universitaria Careggi · Istituto per lo Studio e la Prevenzione Oncologica

    Affiliation as printed

    Azienda Ospedaliera Universitaria Careggi Florence Italy

    Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO) Florence Italy

  16. Istanbul University

    Affiliation as printed

    Istanbul University, Istanbul Faculty of Medicine Istanbul Turkey

  17. University of Minnesota

    Affiliation as printed

    University of Minnesota Minneapolis Minnesota USA

  18. Centre Hospitalier Universitaire de Nantes

    Affiliation as printed

    CHU Hotel Dieu Nantes France

  19. Albert Einstein College of Medicine · Montefiore Medical Center

    Affiliation as printed

    Albert Einstein College of Medicine/Montefiore Medical Center Bronx New York USA

  20. Jens Panse Aachen

    RWTH Aachen University · Universitätsklinikum Aachen

    Affiliation as printed

    Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf Aachen Germany

    University Hospital RWTH Aachen Aachen Germany

  21. Affiliation as printed

    Lakes Research Miami Lakes Florida USA

  22. Essen University Hospital · University of Duisburg-Essen

    Affiliation as printed

    Department of Hematology and Stem Cell Transplantation West German Cancer Centre, University Hospital Essen, University of Duisburg‐Essen Essen Germany

  23. Universität Ulm · German Red Cross

    Affiliation as printed

    Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden‐Württemberg‐Hessen Germany

    Institute of Transfusion Medicine University of Ulm Ulm Germany

  24. Huntsman Cancer Institute

    Affiliation as printed

    Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

  25. Assistance Publique – Hôpitaux de Paris · Université Paris Cité · European Society for Blood and Marrow Transplantation · European Society for Blood and Marrow Transplantation

    Affiliation as printed

    Assistance Publique Hôpitaux de Paris, Université Paris Cité Paris France

    French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Paris France

    The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (UK, Italy and the Netherlands) Barcelona Spain

  26. Novartis (Switzerland)

    Affiliation as printed

    Novartis Pharma AG Basel Switzerland

  27. Novartis (Switzerland)

    Affiliation as printed

    Novartis Pharma AG Basel Switzerland

  28. Affiliation as printed

    China Novartis Institutes For Biomedical Research Co. Ltd Shanghai China

  29. Novartis (Switzerland)

    Affiliation as printed

    Novartis Pharma AG Basel Switzerland

  30. Novartis (Switzerland)

    Affiliation as printed

    Novartis Pharma AG Basel Switzerland

  31. Novartis (Switzerland)

    Affiliation as printed

    Novartis Pharma AG Basel Switzerland

  32. Antonio Maria Risitano corresponding

    University of Naples Federico II · Azienda Ospedaliera S.Giuseppe Moscati · European Society for Blood and Marrow Transplantation · European Society for Blood and Marrow Transplantation

    Affiliation as printed

    AORN Moscati Avellino Italy

    The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (UK, Italy and the Netherlands) Barcelona Spain

    University of Naples Federico II Naples Italy

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-06).

References 34